CIK 0001997296
- Emerging growth company
Medicus Pharma Ltd.
Sign in to watch- Ticker
- MDCX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ontario, Canada
- Entity type
- Operating
- EIN
- 981778211
- Phone
- +1 610-540-7515
- Business address
- 300 CONSHOHOCKEN STATE RD., SUITE 200, W. CONSHOHOCKEN, PA, 19428
Securities
- MDCX Common Stock Nasdaq
- MDCXW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-13 | Smith Andrew Alasdair Chief Operating Officer | Grant or award | +14,534 | $1.72 | $25K | 29,243 |
| 2026-11-13 | Mehmud Faisal Chief Medical Officer | Grant or award | +14,534 | $1.72 | $25K | 43,946 |
| 2026-11-13 | May Sara R. Director | Grant or award | +5,813 | $1.72 | $10K | 5,813 |
| 2026-11-13 | MAHAFFY PATRICK J Director | Grant or award | +14,534 | $1.72 | $25K | 15,243 |
| 2026-11-13 | Kaiser Larry Director | Grant or award | +14,534 | $1.72 | $25K | 14,542 |
| 2026-11-13 | Ciaruffoli Robert J. Director | Grant or award | +72,674 | $1.72 | $125K | 72,924 |
| 2026-11-13 | Brennan Edward J. SVP, Medical Affairs | Grant or award | +14,534 | $1.72 | $25K | 28,029 |
| 2026-11-13 | Bonner Carolyn F. President and CFO | Grant or award | +29,069 | $1.72 | $50K | 58,859 |
| 2026-11-13 | Bokhari Raza Chief Executive Officer | Grant or award | +436,046 | $1.72 | $750K | 451,909 |
| 2026-09-04 | Smith Andrew Alasdair Chief Operating Officer | Grant or award | +735,294 | $0.17 | $125K | 735,458 |
| 2026-09-04 | Smith Andrew Alasdair Chief Operating Officer | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2026-09-04 | Mehmud Faisal Chief Medical Officer | Grant or award | +1,470,588 | $0.17 | $251K | 1,470,588 |
| 2026-09-04 | Mehmud Faisal Chief Medical Officer | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2026-09-04 | Brennan Edward J. Chief Scientific Officer | Grant or award | +588,235 | $0.17 | $100K | 674,735 |
| 2026-09-04 | Brennan Edward J. Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2026-09-04 | Bonner Carolyn F. President and CFO | Grant or award | +1,470,588 | $0.17 | $251K | 1,489,493 |
| 2026-09-04 | Bonner Carolyn F. President and CFO | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2026-09-04 | Bokhari Raza Chief Executive Officer | Grant or award | +2,941,176 | $0.17 | $501K | 2,941,176 |
| 2026-09-04 | Bokhari Raza Chief Executive Officer | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2026-06-03 | Smith Andrew Alasdair Chief Operating Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 |
Page 1 of 4 · 74 trades